Cargando…

Autoimmune Dysfunction Due to Severe Malaria

Despite advances in treatment and prevention, malaria still carries significant morbidity and mortality. Cases of malaria in the United States are rare and cases of severe malaria, mostly attributable to Plasmodium falciparum, are even more uncommon. With the coronavirus disease 2019 (COVID-19) pand...

Descripción completa

Detalles Bibliográficos
Autores principales: Kou, Aretha, Kirschen, Jonathan, Sundaresh, Koravangala, Desai, Parth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239295/
https://www.ncbi.nlm.nih.gov/pubmed/35774704
http://dx.doi.org/10.7759/cureus.25458
_version_ 1784737270506455040
author Kou, Aretha
Kirschen, Jonathan
Sundaresh, Koravangala
Desai, Parth
author_facet Kou, Aretha
Kirschen, Jonathan
Sundaresh, Koravangala
Desai, Parth
author_sort Kou, Aretha
collection PubMed
description Despite advances in treatment and prevention, malaria still carries significant morbidity and mortality. Cases of malaria in the United States are rare and cases of severe malaria, mostly attributable to Plasmodium falciparum, are even more uncommon. With the coronavirus disease 2019 (COVID-19) pandemic, there have been distractions in evaluation and diagnosis leading to a rise in cases and deaths. We present a case of autoimmune dysregulation and blackwater fever secondary to severe malaria, requiring multiple courses of antimalarial therapy. Careful travel history and prompt recognition and treatment facilitates improved patient survival and recovery.
format Online
Article
Text
id pubmed-9239295
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92392952022-06-29 Autoimmune Dysfunction Due to Severe Malaria Kou, Aretha Kirschen, Jonathan Sundaresh, Koravangala Desai, Parth Cureus Internal Medicine Despite advances in treatment and prevention, malaria still carries significant morbidity and mortality. Cases of malaria in the United States are rare and cases of severe malaria, mostly attributable to Plasmodium falciparum, are even more uncommon. With the coronavirus disease 2019 (COVID-19) pandemic, there have been distractions in evaluation and diagnosis leading to a rise in cases and deaths. We present a case of autoimmune dysregulation and blackwater fever secondary to severe malaria, requiring multiple courses of antimalarial therapy. Careful travel history and prompt recognition and treatment facilitates improved patient survival and recovery. Cureus 2022-05-29 /pmc/articles/PMC9239295/ /pubmed/35774704 http://dx.doi.org/10.7759/cureus.25458 Text en Copyright © 2022, Kou et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Kou, Aretha
Kirschen, Jonathan
Sundaresh, Koravangala
Desai, Parth
Autoimmune Dysfunction Due to Severe Malaria
title Autoimmune Dysfunction Due to Severe Malaria
title_full Autoimmune Dysfunction Due to Severe Malaria
title_fullStr Autoimmune Dysfunction Due to Severe Malaria
title_full_unstemmed Autoimmune Dysfunction Due to Severe Malaria
title_short Autoimmune Dysfunction Due to Severe Malaria
title_sort autoimmune dysfunction due to severe malaria
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239295/
https://www.ncbi.nlm.nih.gov/pubmed/35774704
http://dx.doi.org/10.7759/cureus.25458
work_keys_str_mv AT kouaretha autoimmunedysfunctionduetoseveremalaria
AT kirschenjonathan autoimmunedysfunctionduetoseveremalaria
AT sundareshkoravangala autoimmunedysfunctionduetoseveremalaria
AT desaiparth autoimmunedysfunctionduetoseveremalaria